Dirk Bier

Dr. Dirk Bier

Forschungszentrum Juelich GmbH, Institute of Neuroscience and Medicine (INM-5), Juelich, Germany
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1995 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
CWCornelius Weiller
Cornelius Weiller
CIChristian Isensee
Christian Isensee
MRMichel Rijntjes
Michel Rijntjes
WHWalter Huber
Walter Huber
SMStefan Müller
Stefan Müller
HDHans Christoph Diener
Hans Christoph Diener

8 October 2002 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MHMarcus H. Holschbach
Marcus H. Holschbach
RORay A. Olsson
Ray A. Olsson
DBDirk Bier
Dirk Bier
WWWalter Wutz
Walter Wutz
WSWiebke Sihver
Wiebke Sihver
HCHeinz H. Coenen
Heinz H. Coenen

1 March 2004 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PDF file
PMPhilipp T Meyer
Philipp T Meyer
DBDirk Bier
Dirk Bier
MHMarcus H Holschbach
Marcus H Holschbach
CBChristian Boy
Christian Boy
RORay A Olsson
Ray A Olsson
ABAndreas Bauer
Andreas Bauer
Adenosine is an important neuromodulator. Basic cerebral effects of adenosine are exerted by the A1 adenosine receptor (A1AR), which is accessible in vivo by the novel ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) and positron emission tomography (PET). The present study investigates the applicability of kinetic models to describe the cerebral kinetics of [18F]CPFPX in order to quantify A1AR density in vivo. Six healthy volunteers underwent dynamic PET scanning and arterial blood sampling after bolus injection of [18F]CPFPX. For quantitative analysis, a standard two-tissue compartment model (2TCM) was compared with a one-tissue compartment model (1TCM) and Logan's graphical analysis (GA). The 2TCM described the cerebral kinetics of [18F]CPFPX significantly better than the 1TCM (in all regions and subjects examined). The estimated values of the regional total distribution volumes ( DVt) correlated strongly between the 2TCM and GA (linear regression r2 = 0.99, slope: 1.007). The DVt correlation between the 2TCM and the 1TCM was comparably high, but there was a significant bias towards lower DVt estimates given by the 1TCM (r2: 0.99, slope: 0.929). It is concluded that a 2TCM satisfactorily accounts for the cerebral kinetics of [18F]CPFPX. GA represents an attractive alternative method of analysis.

1 December 1989 in Planta
Verified
Journal Article
Closed access
PDF file
SJSiegfried Jahnke
Siegfried Jahnke
DBDirk Bier
Dirk Bier
JEJuan José Estruch
Juan José Estruch
JBJosé Pío Beltrán
José Pío Beltrán

1 January 2006 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MHMarcus H. Holschbach
Marcus H. Holschbach
DBDirk Bier
Dirk Bier
SSS Stusgen
S Stusgen
WWW Wutz
W Wutz
WSW Sihver
W Sihver
ROR Olsson
R Olsson

1 April 2006 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
PDF file
DBDirk Bier
Dirk Bier
MHMarcus H. Holschbach
Marcus H. Holschbach
WWWalter Wutz
Walter Wutz
RORay A. Olsson
Ray A. Olsson
HCHeinz H. Coenen
Heinz H. Coenen
Studies of plasma from mice, rats, and human volunteers evaluated methods for the extraction and quantification of the positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) and identification of its metabolites in plasma by thin-layer chromatography and high-performance liquid chromatography (HPLC). Analysis of human, mouse, and rat plasma extracts by HPLC identified four identical radioactive metabolites in each species. The low mass of radioligand administered to humans (0.5 - 5 nmol) prevented direct identification of metabolites. However, incubating liver microsomes with CPFPX and analysis by means of liquid chromatography-mass spectrometry (LC-MS) identified seven compounds, four having the same retention times as the metabolites in human plasma. Analysis of microsomal metabolites by LC-MS identified five [M + H]+ ions of m/z equivalent to hydroxy derivatives, 339, one of m/z equivalent to an oxo derivative, m/z 337, and one of m/z equivalent to a difunctionalized oxo-desaturation species, m/z 335, which is prominent in rat and mouse plasma and is the main metabolite in human plasma. An [M + H]+ ion corresponding to a N-dealkylated derivative was not detected. Thus, like the natural methylxanthines, CPFPX seems to undergo oxidation by liver microsomes but, unlike those methylxanthines, dealkylation did not occur. LC-MS experiments with “in source” fragmentation identified the cyclopentyl moiety to be the most functionalized part of the molecule by liver microsomes and in vivo oxidations. Except for two metabolites, hydroxylated at the N1 propyl chain, all oxidative modifications found took place at the cyclopentyl ring.